Current Studies

Curis is conducting clinical trials to evaluate the efficacy and safety of an investigational drug (CA-4948) in cancer. All currently enrolling clinical trials for emavusertib (CA-4948) can be found on clinicaltrials.gov.

Sponsored

A Study of CA-4948 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma

Recruitment icon
Ages icon
Recruitment Status:
Recruiting
Ages Eligible for Study:
18 Years +

Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With AML or MDS

Recruitment icon
Ages icon
Recruitment Status:
Recruiting
Ages Eligible for Study:
18 Years +